The Atypical Face of Neuroleptic Malignant Syndrome: A Case Report of Ileus and Absent Rigidity

被引:0
|
作者
Kutumbaka, Tarun [1 ]
Varadan, Sivaprakash [1 ]
Singh, R. B. Sudagar [2 ]
机构
[1] Sri Ramachandra Inst Higher Educ & Res, Gen Med, Chennai, India
[2] Sri Ramachandra Inst Higher Educ & Res, Internal Med, Chennai, India
关键词
drug-induced hyperthermia; rhabdomyolysis; paralytic ileus; antipsychotic medication; neuroleptic malignant syndrome (nms);
D O I
10.7759/cureus.63784
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuroleptic malignant syndrome (NMS) is a rare life-threatening condition associated with the use of antipsychotic medications. This case report describes a male patient in his early 30s who presented with fever, breathlessness, and lower limb weakness, ultimately diagnosed with NMS despite the absence of muscular rigidity. On examination, he was febrile, tachycardic, and tachypneic with an oxygen saturation of 88% and elevated blood pressure. On auscultation diffuse crepitations in both lungs were revealed. Neurological assessment indicated motor strength of 3/5 in both lower limbs, without rigidity, sensory loss, or cerebellar signs. It was noted that he was on irregular atypical antipsychotic medication for the past one year. Laboratory investigations revealed leukocytosis, elevated transaminases, dyselectrolytemia, elevated creatine phosphokinase (CPK), and serum creatinine. NMS was not initially considered due to the lack of muscular rigidity. However, the patient later developed autonomic dysregulation manifestations, such as paralytic ileus. Once organic causes were excluded, NMS was diagnosed. Supportive therapy included 23 cycles of hemodialysis and colonic decompression for pseudo-obstruction. He was treated with intravenous fluids and dopamine receptor agonist medications. NMS usually presents with fever, muscular rigidity, altered mental status, and autonomic instability; yet, the absence of muscular rigidity in this patient is a distinctive and unusual feature.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Atypical neuroleptic malignant syndrome - A case report
    Vellekkatt, Favaz
    Kuppili, Pooja Patnaik
    Bharadwaj, Balaji
    Menon, Vikas
    ASIAN JOURNAL OF PSYCHIATRY, 2019, 43 : 7 - 8
  • [2] Atypical form of neuroleptic malignant syndrome: A case report
    Supe, S
    Alvir, D
    Matijevic, V
    Petravic, D
    NEUROLOGIA CROATICA, 2001, 50 (3-4): : 165 - 170
  • [3] NEUROLEPTIC MALIGNANT SYNDROME AND ATYPICAL ANTIPSYCHOTICDRUGS: A CASE REPORT
    Diaz, G.
    Suarez, M. N.
    Quandt, P.
    Gonzalez, I.
    Vera, E.
    Hernandez, A.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [4] Atypical neuroleptic malignant syndrome: case report and discussion
    Elkarimi, M. E.
    Meftah, A.
    Filali, H.
    Belmouden, A.
    Hakkou, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 12 - 12
  • [5] Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report
    El Khoury, Rhea
    Kassab, Anthony
    Dagher, Ramez
    Javelot, Herve
    El Chammay, Rabih
    Richa, Sami
    JOURNAL OF PSYCHIATRIC PRACTICE, 2020, 26 (04) : 320 - 323
  • [6] Ileus as a Sign of Neuroleptic Malignant Syndrome: A Case Report and Review of the Literature
    Elyasi, Forouzan
    Azizi, Marzieh
    Shirzad, Mahboobeh
    Ghasemian, Roya
    Kazemi, Arash
    Lavvaf, Sabahat
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2018, 12 (03)
  • [7] MALIGNANT NEUROLEPTIC SYNDROME - ATYPICAL CASE
    BERNSTEIN, RA
    PSYCHOSOMATICS, 1979, 20 (12) : 840 - &
  • [8] Atypical Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report
    Grant, Heidi
    BJPSYCH OPEN, 2023, 9 : S122 - S123
  • [9] Paliperidone-associated atypical neuroleptic malignant syndrome: A case report
    Han, Changsu
    Lee, Soo-Jung
    Pae, Chi-Un
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02): : 650 - 651
  • [10] A Case Report Atypical Neuroleptic Malignant Syndrome on Clozapine and Mood Stabilizers
    Amador, Emily C.
    Kassam, Areef
    Hopp, Chrissy
    Cunningham, Elizabeth A.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (05) : 518 - 519